Laurent Lessard

1.5k citations
25 papers · 1.3k indexed · h-index 17
Topics
NF-κB Signaling Pathways (11 papers)Prostate Cancer Treatment and Research (5 papers)Cancer, Lipids, and Metabolism (3 papers)

In The Last Decade

Laurent Lessard

25 papers receiving 1.2k citations

Peers

Laurent Lessard
Comparison fields: 5 of 85
  • Molecular Biology 811
  • Cancer Research 528
  • Oncology 359
  • Pulmonary and Respiratory Medicine 259
  • Immunology 225
Replace Yijun Shu with:
Yijun Shu China
Runfa Bao China
Huiling Yang China
Subbulakshmi Virudachalam United States
Xingjun Guo China
Stina Garvin Sweden
Tasuku Matsuoka Japan
Rong Ma China
Pat Gulhati United States
Gong‐Kan Feng China
Laurent Lessard relative to Yijun Shu China Yijun Shu's profile →
Citations per field
00.5×1.5×2.3×
Yijun Shu · 1×
Citations per year

Countries citing papers authored by Laurent Lessard

Since Specialization
Citations

This map shows the geographic impact of Laurent Lessard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Lessard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Lessard more than expected).

Fields of papers citing papers by Laurent Lessard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Lessard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Lessard. The network helps show where Laurent Lessard may publish in the future.

Co-authorship network of co-authors of Laurent Lessard

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Lessard. A scholar is included among the top collaborators of Laurent Lessard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Lessard. Laurent Lessard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 10
3 88
4 1
5 7
6 41
7 41
8 69
9 32
10 177
11 16
12 1
13 26
14 24
15 17
16 27
17 52
18 122
19 105
20 84

About Laurent Lessard

Laurent Lessard is a scholar working on Cancer Research, Immunology and Allergy and Immunology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (11 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (528 citations), Oncology (359 citations) and Molecular Biology (811 citations). Laurent Lessard has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Anne‐Marie Mes‐Masson, Fred Saad, Michel L. Tremblay, Matthew Stuible, Louis R. Bégin, Cécile Le Page, Ismaël Hervé Koumakpayi, Pierre I. Karakiewicz, Jean‐Simon Diallo and L.R. Bégin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026